Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma.
Roderwieser A, Sand F, Walter E, Fischer J, Gecht J, Bartenhagen C, Ackermann S, Otte F, Welte A, Kahlert Y, Lieberz D, Hertwig F, Reinhardt HC, Simon T, Peifer M, Ortmann M, Büttner R, Hero B, O'Sullivan RJ, Berthold F, Fischer M.
Roderwieser A, et al.
JCO Precis Oncol. 2019 Dec;3:1-20. doi: 10.1200/PO.19.00072.
JCO Precis Oncol. 2019.
PMID: 35100718